MK

Mushfique Khan

Active Director Director DIN 08022615
DIN 08022615 First appointment Jan 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2018
Shareholding value •••• Premium profile

About Mushfique Khan

Data last updated:

Mushfique Khan is a Director at Strange Pharmaceutical Private Limited (since 2018). The company operates in Pharma. Strange Pharmaceutical Private Limited reported revenue of ₹3.4 Lakh (FY 2020).

DIN 08022615
Primary Designation Director
Industry Pharma
First Appointment 18 Jan 2018
Oldest Company Age 8 yrs
Largest company Strange Pharmaceutical Private Limited · ₹3.4 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Jan 20182018₹3.4 Lakh (FY 2020)Active

Board colleagues of Mushfique Khan

Directorship timeline

Open interactive timeline →
Strange Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Mushfique Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mushfique Khan

Mushfique Khan currently holds 1 directorship: Strange Pharmaceutical Private Limited (Director, since 18 Jan 2018, revenue ₹3.4 Lakh (FY 2020)).

Mushfique Khan was first appointed on 18 Jan 2018 as Director at Strange Pharmaceutical Private Limited.

The current boards of Mushfique Khan's companies include Himanshu Soni (Strange Pharmaceutical Private Limited), Mohammad Aslam (Strange Pharmaceutical Private Limited), Mohd Altaf (Strange Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available